Company intelligence / Profile preview

DT MedTech

Baltimore, Maryland, United Statesdtmedtech.com ↗

Ownership: Private
Employees: ~2
Development stage: Commercial

Overview

The Hintermann Series H2® Total Ankle Replacement system received FDA clearance for the US market; the Hintermann Series H3® mobile-bearing system received FDA PMA approval in June 2019. Both systems have demonstrated strong clinical results internationally over more than 17 years of use. The products are sold in over 30 countries with a full US launch of the H3 planned after acquisition by Vilex.

Therapeutic areas: Rheumatology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

European Foot Platform S.A.R.L.Prof. Beat Hintermann (inventor/collaborator)

Beyond the preview

Go deeper on DT MedTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DT MedTech.

Explore the full profile